Laura Prendergast
Stock Analyst at Stifel Nicolaus
(4.27)
# 1,334
Out of 4,334 analysts
68
Total ratings
45.1%
Success rate
21.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Laura Prendergast
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNGX Tango Therapeutics | Maintained: Buy | $40 | $20.04 | +99.60% | 9 | May 25, 2026 | |
| ERAS Erasca | Maintained: Buy | $30 | $11.50 | +160.87% | 10 | May 25, 2026 | |
| BDTX Black Diamond Therapeutics | Maintained: Buy | $8 | $2.33 | +243.35% | 6 | May 22, 2026 | |
| BBOT BridgeBio Oncology Therapeutics | Maintained: Buy | $23 | $8.37 | +174.79% | 4 | May 13, 2026 | |
| RVMD Revolution Medicines | Maintained: Buy | $215 | $154.89 | +38.81% | 16 | May 7, 2026 | |
| FHTX Foghorn Therapeutics | Maintained: Buy | $12 | $4.37 | +174.60% | 5 | Apr 27, 2026 | |
| NUVL Nuvalent | Maintained: Buy | $135 | $104.95 | +28.63% | 5 | Apr 27, 2026 | |
| COGT Cogent Biosciences | Maintained: Buy | $45 | $33.94 | +32.59% | 7 | Mar 3, 2026 | |
| OLMA Olema Pharmaceuticals | Initiated Coverage: Buy | $48 | $13.55 | +254.24% | 1 | Feb 11, 2026 | |
| HLIT Harmonic | Maintained: Buy | $12 | $16.90 | -28.99% | 3 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $8.35 | n/a | 1 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $16 | $3.06 | n/a | 1 | Aug 14, 2024 |
Tango Therapeutics
May 25, 2026
Maintained: Buy
Price Target: $40
Current: $20.04
Upside: +99.60%
Erasca
May 25, 2026
Maintained: Buy
Price Target: $30
Current: $11.50
Upside: +160.87%
Black Diamond Therapeutics
May 22, 2026
Maintained: Buy
Price Target: $8
Current: $2.33
Upside: +243.35%
BridgeBio Oncology Therapeutics
May 13, 2026
Maintained: Buy
Price Target: $23
Current: $8.37
Upside: +174.79%
Revolution Medicines
May 7, 2026
Maintained: Buy
Price Target: $215
Current: $154.89
Upside: +38.81%
Foghorn Therapeutics
Apr 27, 2026
Maintained: Buy
Price Target: $12
Current: $4.37
Upside: +174.60%
Nuvalent
Apr 27, 2026
Maintained: Buy
Price Target: $135
Current: $104.95
Upside: +28.63%
Cogent Biosciences
Mar 3, 2026
Maintained: Buy
Price Target: $45
Current: $33.94
Upside: +32.59%
Olema Pharmaceuticals
Feb 11, 2026
Initiated Coverage: Buy
Price Target: $48
Current: $13.55
Upside: +254.24%
Harmonic
Jul 29, 2025
Maintained: Buy
Price Target: $12
Current: $16.90
Upside: -28.99%
Feb 13, 2025
Maintained: Buy
Price Target: $4
Current: $8.35
Upside: n/a
Aug 14, 2024
Upgraded: Buy
Price Target: $16
Current: $3.06
Upside: n/a